Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apoptotic regulators in granulosa cells comprise a complex network of proteins and signaling pathways that govern the survival and programmed death of somatic cells within the ovarian follicle (Tilly et al., 1991, PMID: 1906954). Granulosa cells are vital for oocyte development, and their apoptosis is the primary driver of follicular atresia, a process that eliminates the majority of follicles during the reproductive lifespan. Key regulators include the Bcl-2 family, such as pro-apoptotic Bax and anti-apoptotic Bcl-2, as well as the caspase protease family and the Fas/Fas ligand system (Hussein, 2005, PMID: 16125327; Manabe et al., 2004, PMID: 15131305). Survival signals are primarily mediated by gonadotropins like follicle-stimulating hormone (FSH) and growth factors like IGF-1, which suppress apoptotic pathways. Dysregulation of these regulators is central to the pathogenesis of polycystic ovary syndrome (PCOS), where apoptosis is often reduced, and premature ovarian failure (POF), where it is accelerated (Das et al., 2008, PMID: 18258680). Pharmacological intervention typically involves using gonadotropins to prevent apoptosis during controlled ovarian stimulation or addressing the off-target apoptotic effects of chemotherapy on the ovarian reserve. Understanding these regulators is also crucial for developing targeted therapies for ovarian malignancies where apoptotic pathways are often evaded.
Modulation of the ratio between pro-apoptotic (e.g., Bax, Caspases) and anti-apoptotic (e.g., Bcl-2, XIAP) proteins to determine cell fate.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apoptotic regulators in granulosa cells.